|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
71,621,000 |
Market
Cap: |
3.82(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$34.89 - $62.42 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Merus is a clinical-stage oncology company developing antibody therapeutics. Using its Biclonics® platform, Co. has produced and is developing the following candidates: MCLA-128 (zenocutuzumab) for the treatment of solid tumors that harbor Neuregulin 1 gene fusions; MCLA-117 for the treatment of acute myeloid leukemia; MCLA-158 for the treatment of solid tumors; and MCLA-145, developed in collaboration with Incyte Corporation, for the potential treatment of solid tumors and a hematological malignancy, B-cell lymphoma. Co. is also developing a late-stage pre-clinical candidate, MCLA-129 in collaboration with Betta Pharmaceuticals Co. Ltd., for the potential treatment of solid tumors.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
4,000 |
4,000 |
81,000 |
118,626 |
Total Sell Value |
$193,990 |
$193,990 |
$4,568,168 |
$5,943,940 |
Total People Sold |
1 |
1 |
2 |
2 |
Total Sell Transactions |
1 |
1 |
5 |
12 |
End Date |
2025-03-16 |
2024-12-13 |
2024-06-14 |
2023-06-15 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Lundberg Sven Ante |
President, CEO & PEO |
|
2025-04-17 |
4 |
OE |
$12.54 |
$405,894 |
D/D |
30,297 |
30,297 |
|
- |
|
Shuman Harry |
VP Controller, PAO |
|
2025-03-21 |
4 |
S |
$48.48 |
$193,990 |
D/D |
(4,000) |
11,002 |
|
-16% |
|
Shuman Harry |
VP Controller, PAO |
|
2025-03-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
15,002 |
|
- |
|
Lundberg Sven Ante |
President, CEO & PEO |
|
2025-02-19 |
4 |
GA |
$0.00 |
$0 |
I/I |
40,601 |
40,601 |
|
- |
|
Lundberg Sven Ante |
President, CEO & PEO |
|
2025-02-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
40,601 |
0 |
|
- |
|
Lundberg Sven Ante |
President, CEO & PEO |
|
2025-02-13 |
4 |
OE |
$24.43 |
$399,968 |
D/D |
16,372 |
40,601 |
|
- |
|
Shuman Harry |
VP Controller, PAO |
|
2025-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
12,002 |
|
- |
|
Shuman Harry |
VP Controller, PAO |
|
2024-08-21 |
4 |
S |
$54.00 |
$135,000 |
D/D |
(2,500) |
7,002 |
|
22% |
|
Shuman Harry |
VP Controller, PAO |
|
2024-08-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
9,502 |
|
- |
|
Shuman Harry |
VP Controller, PAO |
|
2024-08-20 |
4 |
S |
$54.00 |
$135,000 |
D/D |
(2,500) |
7,002 |
|
22% |
|
Shuman Harry |
VP Controller, PAO |
|
2024-08-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
9,502 |
|
- |
|
Silverman Peter B. |
COO & GC |
|
2024-06-27 |
4 |
AS |
$60.00 |
$600,000 |
D/D |
(10,000) |
0 |
|
-14% |
|
Silverman Peter B. |
COO & GC |
|
2024-06-27 |
4 |
OE |
$17.94 |
$179,400 |
D/D |
10,000 |
10,000 |
|
- |
|
Silverman Peter B. |
COO & GC |
|
2024-06-17 |
4 |
AS |
$56.52 |
$3,504,178 |
D/D |
(62,000) |
0 |
|
-5% |
|
Silverman Peter B. |
COO & GC |
|
2024-06-17 |
4 |
OE |
$17.94 |
$1,510,280 |
D/D |
62,000 |
62,000 |
|
- |
|
Shuman Harry |
VP Controller, PAO |
|
2024-06-12 |
4 |
S |
$57.84 |
$422,232 |
D/D |
(7,300) |
7,002 |
|
6% |
|
Shuman Harry |
VP Controller, PAO |
|
2024-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,300 |
14,302 |
|
- |
|
Shuman Harry |
VP Controller, PAO |
|
2024-06-10 |
4 |
S |
$53.22 |
$53,224 |
D/D |
(1,000) |
7,002 |
|
1% |
|
Shuman Harry |
VP Controller, PAO |
|
2024-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,000 |
8,002 |
|
- |
|
Shuman Harry |
VP Controller, PAO |
|
2024-06-04 |
4 |
S |
$52.85 |
$317,354 |
D/D |
(6,000) |
7,002 |
|
-4% |
|
Shuman Harry |
VP Controller, PAO |
|
2024-06-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
8,002 |
|
- |
|
Shuman Harry |
VP Controller, PAO |
|
2023-12-19 |
4 |
S |
$26.68 |
$3,068 |
D/D |
(115) |
7,002 |
|
-75% |
|
Silverman Peter B. |
COO & GC |
|
2023-12-15 |
4 |
S |
$25.00 |
$559,650 |
D/D |
(22,386) |
0 |
|
-79% |
|
Silverman Peter B. |
COO & GC |
|
2023-12-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,386 |
22,386 |
|
- |
|
Shuman Harry |
VP Controller, PAO |
|
2023-12-08 |
4 |
S |
$24.44 |
$6,110 |
D/D |
(250) |
7,117 |
|
-69% |
|
129 Records found
|
|
Page 1 of 6 |
|
|